Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients

NCT03137264 · clinicaltrials.gov ↗

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Other

Sponsor

AstraZeneca

Collaborators

[object Object]